← Back to Search

Robotic Arm Therapy for Stroke

Phase 1
Waitlist Available
Led By Lauren McDonagh, PT
Research Sponsored by Kessler Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Head, neck, and trunk control to maintain an upright posture for a minimum of 45 minutes
Active shoulder flexion and/or abduction greater than 30 degrees
Timeline
Screening 3 weeks
Treatment Varies
Follow Up start and end of treatment
Awards & highlights

Study Summary

This trial will test whether adding robotic therapy to standard occupational therapy can help stroke patients recover arm movement faster and more accurately.

Who is the study for?
This trial is for right-handed individuals aged 65-84 who've had a right hemisphere ischemic stroke within the last 15 days, leading to arm weakness. They must be able to follow commands and maintain an upright posture for at least 45 minutes with some shoulder movement and elbow flexion. Those with previous strokes, certain types of stroke, severe muscle tone issues or contractures, full limb movement, poor vision, or unstable health conditions that affect exercise cannot join.Check my eligibility
What is being tested?
The study compares standard occupational therapy against a mix of conventional therapy and robotic assistance using the Reo Go device. This device aims to improve arm function in acute stroke patients by helping them perform more precise movements during rehabilitation.See study design
What are the potential side effects?
While not explicitly mentioned here, potential side effects may include discomfort from repetitive movements or fatigue due to intensive training sessions with the robotic arm trainer.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can sit up straight without support for at least 45 minutes.
Select...
I can lift my arm above 30 degrees without help.
Select...
I am right-handed and between 65-84 years old.
Select...
I had a stroke in the right side of my brain less than 15 days ago, causing arm weakness.
Select...
I can bend my elbow at least 45 degrees.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~start and end of treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and start and end of treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Fugl-Meyer Score
Secondary outcome measures
EMG - muscle activation and co-contraction index

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Robotic and Conventional TherapyExperimental Treatment1 Intervention
Group II: Conventional TreatmentActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Kessler FoundationLead Sponsor
173 Previous Clinical Trials
10,668 Total Patients Enrolled
2 Trials studying Paresis
172 Patients Enrolled for Paresis
Kessler Institute for RehabilitationIndustry Sponsor
22 Previous Clinical Trials
1,125 Total Patients Enrolled
Lauren McDonagh, PTPrincipal InvestigatorKessler Rehabilitation Institute

Media Library

Conventional Therapy Clinical Trial Eligibility Overview. Trial Name: NCT00785343 — Phase 1
Paresis Research Study Groups: Robotic and Conventional Therapy, Conventional Treatment
Paresis Clinical Trial 2023: Conventional Therapy Highlights & Side Effects. Trial Name: NCT00785343 — Phase 1
Conventional Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT00785343 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this specific research trial open to participants aged 55 or above?

"This research initiative is seeking applicants between the ages of 65 and 84. Reportedly, there are 1072 trials available for those over 65 while 53 have been opened up to younger individuals."

Answered by AI

Are there presently opportunities for patients to participate in this study?

"According to information on clinicaltrials.gov, this particular medical trial is not enrolling patients at present; it was initially posted in September 2008 and last updated in December 2009. However, there are 1128 other studies which currently accept participants."

Answered by AI

To what degree can use of the Reo Go robotic arm trainer be detrimental to patients?

"Due to the fledgling nature of this trial, Power has given Reo Go robotic arm trainer a score of 1 on their safety scale. This assessment is based on initial data suggesting efficacy and limited evidence supporting its security measures."

Answered by AI

What is the eligibility criteria for involvement in this clinical trial?

"To qualify for this trial, individuals aged 65 to 84 who are exhibiting paresis must be recruited. Thus far, approximately 40 people have been accepted into the study."

Answered by AI
~2 spots leftby Apr 2025